Original from: QIAGEN QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for Q2 2026, with net sales and adjusted diluted earnings per share exceeding the outlook while maint..

Original from: Merck Financial Highlights - Total Worldwide Sales Were $16.6 Billion (5% Growth; 4% Growth ex-FX) · KEYTRUDA/KEYTRUDA QLEX1 Sales Were $8.4 Billion (5% Growt..

Original from: Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the second quart..

Original from: Revvity Revvity, Inc. (NYSE: RVTY), today reported financial results for the second quarter ended July 5, 2026. The Company reported GAAP earnings per share from continuing o..

2.2.3 AVE-752 Full Automated Urine Analyzer Produced by AVE, it has a high degree of automation, and the front end is equipped with automatic sample delivery device. 1. Structure: It consis..

Original from: Globe Newswire Eyonis Inc., a Median Technologies company focused on applying artificial intelligence to the early detection and diagnosis of cancer, today announced that Median Technologi..

Original from: PR Newswire Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diab..

Roche and Beckman Coulter Win Bids for PUMCH Laboratory Automation Systems Peking Union Medical College Hospital (PUMCH) has awarded contracts to Roche and Beckman Coulter for two automate..

Original from: Diasorin The Board of Directors of Diasorin S.p.A. (FTSE MIB: DIA) meeting today, examined and approved the Group’s Consolidated Financial Statements at June 30, 2026. ..

Original from: Siemens Healthineers Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2026 ended June 30, 2026. Q3 Fiscal Year 2026 • Outs..

Original from: Guardant Health Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended June 30, 2026. Second Quarter..

Original from: Illumina Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026. Second quarter 2026 res..

Original from: RESPIRATORY THERAPY Intelligenome and Cornell University entered into a research and development subaward agreement to support the development of a rapid, low-cost, and portable diagnostic..

Original from: PR Newswire Alveo Technologies, Inc. (Alveo), a leader in portable molecular sensing solutions, today announced a strategic partnership with The University of Texas Medical Branch (UTMB) t..

Original from: bioMérieux bioMérieux, a world leader in the field of in vitro diagnostics, today announces the submission of the BIOFIRE® FILMARRAY® Gastrointestinal 1.1 (GI1.1) Panel and the B..